|
TRIM13 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.594320E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.343150E-01 |
| Normal-vs-Stage2 |
3.186300E-02 |
| Normal-vs-Stage3 |
7.821200E-04 |
| Normal-vs-Stage4 |
2.059000E-03 |
| Stage1-vs-Stage2 |
2.083600E-01 |
| Stage1-vs-Stage3 |
8.560400E-03 |
| Stage1-vs-Stage4 |
3.177700E-02 |
| Stage2-vs-Stage3 |
5.431000E-01 |
| Stage2-vs-Stage4 |
5.078800E-01 |
| Stage3-vs-Stage4 |
8.698400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.078400E-03 |
| Normal-vs-AfricanAmerican |
1.369960E-01 |
| Normal-vs-Asian |
4.074200E-01 |
| Caucasian-vs-AfricanAmerican |
9.293000E-01 |
| Caucasian-vs-Asian |
1.366160E-01 |
| AfricanAmerican-vs-Asian |
3.757000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.479900E-02 |
| Normal-vs-Female |
1.258280E-02 |
| Male-vs-Female |
6.126400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.593760E-01 |
| Normal-vs-Age(41-60Yrs) |
2.489500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.575810E-03 |
| Normal-vs-Age(81-100Yrs) |
3.394300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.466200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.446080E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.276240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.252430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.417400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.585200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.035500E-04 |
| Classical-VS-Follicular |
1.127380E-01 |
| Classical-VS-Other |
9.880800E-01 |
| Classical-VS-Normal |
1.022840E-01 |
| Tall-VS-Follicular |
8.720500E-02 |
| Tall-VS-Other |
2.779000E-01 |
| Tall-VS-Normal |
1.799570E-04 |
| Follicular-VS-Other |
6.339400E-01 |
| Follicular-VS-Normal |
2.179700E-02 |
| Other-VS-Normal |
5.459800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.832340E-02 |
| Normal-vs-N1 |
1.459720E-02 |
| N0-vs-N1 |
6.965000E-01 |
|
|
